We investigated the expression and cell localization of NOTCH1, NOTCH4, and the delta-like ligand DLL4 in corpus luteum (CL) from pregnant rats during prostaglandin F2alpha (PGF2alpha)-induced luteolysis. We also examined serum progesterone (P 4 ) and CL proteins related to apoptosis after local administration of the notch inhibitor N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine t-butyl ester (DAPT). Specific staining for NOTCH1 and NOTCH4 receptors was detected predominantly in large and small luteal cells. Furthermore, in line with the fact that the notch intracellular domain is translocated to the nucleus, where it regulates gene expression, staining was evident in the nuclei of luteal cells. In addition, we detected diffuse cytoplasmic immunostaining for DLL4 in small and large luteal cells, in accordance with the fact that DLL4 undergoes proteolytic degradation after receptor binding. The mRNA expression of Notch1, Notch4, and Dll4 in CL isolated on Day 19 of pregnancy decreased significantly after administration of PGF2alpha. Consistent with the mRNA results, administration of PGF2alpha to pregnant rats on Day 19 of pregnancy decreased the protein fragment corresponding to the cleaved forms of NOTCH1/4 CL receptors. In contrast, no significant changes were detected in protein levels for the ligand DLL4. The local intrabursal administration of DAPT decreased serum P 4 levels and increased luteal levels of active caspase 3 and the BAX:BCL2 ratio 24 h after the treatment. These results support a luteotropic role for notch signaling to promote luteal cell viability and steroidogenesis, and they suggest that the luteolytic hormone PGF2alpha may act in part by reducing the expression of some notch system members. apoptosis, corpus luteum, ovary, pregnancy, progesterone/ progesterone receptor
INTRODUCTION
The corpus luteum (CL) is a transient endocrine gland, the main function of which is to secrete the steroid hormone progesterone (P 4 ), essential for implantation of the blastocyst and maintenance of pregnancy in mammals [1] [2] [3] . If pregnancy does not occur, however, or when P 4 is no longer required for the maintenance of pregnancy, the CL ceases to produce this hormone and regresses in a process called luteolysis. The formation and regression of the CL require rapid remodeling, growth, differentiation, and death of its heterogeneous population of cells. During luteolysis, the death of luteal cells is preceded by a loss of their capacity to synthesize and secrete P 4 [4] .
Prostaglandin F2alpha (PGF2a) is a uterine-derived factor that initiates luteolysis in many nonprimate species. Interestingly, the prostaglandin synthesis inhibitor indomethacin prevents luteolysis in pseudopregnant rodents [5] . The actions of PGF2a include a reduction in ovarian blood flow, uncoupling of the luteinizing hormone (LH) receptor from adenylate cyclase, reduction in steroidogenic enzyme activity and P 4 production, a decrease in LH receptor concentration, changes in membrane fluidity, changes in luteal cell population, and an increase in lysosomal enzyme activity [6] [7] [8] . Although PGF2a has been well established as the most important luteolytic hormone for more than 30 years, the cellular mechanisms by which PGF2a exerts its luteolytic effects remain incompletely understood.
Luteal regression has been related to apoptosis in many species [9] [10] [11] [12] [13] [14] [15] [16] . Several genes belonging to the Bcl2 family may function as intracellular mediators of cell survival. The protein products of the Bcl2 and Bax genes have been described as anti-and proapoptotic factors, respectively [17] [18] [19] . Depending on the balance of these proteins, the initiator caspase 9 (CASP9) is activated, and several effectors caspases, such as CASP3 or CASP7, are sequentially activated and promote apoptosis in various systems [20] . In previous studies, we reported the expression and activation of proapoptotic caspasemediated pathways during both spontaneous luteolysis in pregnancy and natural cycles as well as PGF2a-induced luteolysis [21, 22] .
The notch pathway includes a conserved family of transmembrane receptors (NOTCH1, NOTCH2, NOTCH3, and NOTCH4) that interact with a number of specific ligands (the delta-like family, jagged [JAG] 1, and JAG2) to regulate cell fate [23] . Notch signaling plays a critical role in many developmental processes, influencing differentiation, proliferation, and apoptosis [24, 25] . In addition, notch family members, particularly delta-like ligand (DLL4) and its receptors NOTCH1 and NOTCH4, have been recently identified as novel factors involved in the regulation of angiogenesis [26, 27] . The interaction between notch receptors and their ligands leads to intracellular cleavage of notch receptors by the gamma-secretase complex [28] . The cleaved notch intracellular domain (NICD) traffics to the nucleus, where it interacts with transcriptional factors. This processing requires the activity of two proteases-namely, tumor necrosis factor a-converting enzyme and presenilin/gamma-secretase. Johnson et al. [29] have examined the expression patterns of notch receptor genes and their ligands by immunohistochemistry (IHC) in rodent mammalian ovary. Their data indicate that NOTCH2, NOTCH3, and JAG2 are expressed in an overlapping pattern in the granulosa cells of developing follicles. However, the expression and regulation of the notch ligand-DLL4 system in the structure-function of CL remain unknown. We thus hypothesized that if the notch system plays a key role in luteolysis during pregnancy in rats, then Notch mRNA and/ or protein expression would change in PGF2a-induced CL regression. Therefore, studies were designed to analyze the expression and cell localization of NOTCH1, NOTCH4, and the ligand DLL4 in CL from pregnant rats during PGF2a-induced luteolysis. To elucidate whether the notch system has a direct effect in luteal function during pregnancy, we also examined serum P 4 and proteins related to apoptosis in rat CL after local administration of the gamma-secretase inhibitor N-
MATERIALS AND METHODS

Animal Model
Adult female Sprague-Dawley rats (body weight, 200-250 g; age, 8 wk) were housed at room temperature (21-238C) with a 12L:12D photoperiod in an air-conditioned environment. The rats had ad libitum access to food and water. Animals showing three consecutive 4-day cycles were used for the experiment, and cycling stages were determined daily by vaginal cytology. Proestrous females were caged with fertile males overnight; after separation the next morning, vaginal smears were analyzed for the presence of spermatozoa. The day spermatozoa were detected was considered to be Day 1 of pregnancy.
For prostaglandin experiments, a group of rats was injected intraperitoneally with 400 lg of analogue (PGF2a group; Lutalyse; Pfizer) on Day 19 of pregnancy to induce luteolysis, and another group of animals was injected with saline solution (control group). The animals were euthanized by CO 2 aspiration, and ovaries were collected at 4 and 24 h after treatment. Day 19 of pregnancy was selected for PGF2a treatment, because this is when the CL becomes more sensitive to the action of PGF2a [30] .
For the inhibition of the notch pathway, DAPT (Sigma-Aldrich), a chemical component that specifically inhibits the activity of the gamma-secretase complex, was used. This inhibitor has been extensively used for experimental studies of notch signaling, both in vitro and in vivo [31] . Pregnant rats were anesthetized on Day 19 of pregnancy with ketamine HCl (70 mg/kg; HollidayScott S.A.) and xylazine (5 mg/kg; König Laboratories). The ovaries were exteriorized through an incision made in the ventral region. One group of rats then received 10 lg of DAPT (1 lg/ll) under the bursa of both ovaries (DAPT group), and another group of animals received 10 ll of vehicle solution (6% dimethyl sulfoxide; control group). Twenty-four hours after the surgery, animals were euthanized by decapitation for ovary and blood collection. The experimental protocols were approved by the Animal Experimentation Committee of the Institute of Experimental Biology and Medicine (IBYME-CONICET).
Tissue Preparation
Corpora lutea were dissected from ovaries under a stereoscopic microscope as previously described [22, 32] . Pools of CL (n ¼ 5-6 CL/rat) were frozen in liquid nitrogen and stored at À808C for mRNA and protein extraction. Also, half of each ovary was fixed for IHC studies.
Immunohistochemistry
Ovaries from the different groups were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) at 48C for 12 h. Tissues were dehydrated in a series of ethanol solutions (70%, 96%, and 100%) and embedded in paraffin. Then, sections (thickness, 4 lm) were deparaffinized and hydrated with xylene and a graded series of ethanol. Endogenous peroxidases were then quenched with 3% H 2 O 2 in PBS, followed by successive PBS washes. To study the localization of CASP3 protein, the slides were heated in a microwave oven in a citric acid buffer (0.01 M, pH 6) for 9 min at 600 W, followed by 20 min of cooling at room temperature. For NOTCH1, NOTCH4, and DLL4 proteins, the slides were exposed to proteinase K in PBS (20 mg/ml) for 15 min, followed by two successive washes with distilled water. All primary antibodies were purchased from Santa Cruz Biotechnology. Sections were placed in a blocking buffer (2% bovine serum albumin in PBS) for 20 min, and then incubated with the primary antibody at a concentration of 1:100 in PBS buffer for 1 h at room temperature. Finally, all sections were incubated overnight at 48C.
The primary antibody was detected using a biotinylated anti-rabbit immunoglobulin (Ig) G secondary antibody (1:400; Vector Laboratories) and the Vector ABC-Elite Kit. Positive-stained slides were visualized with 3,5-diaminobenzide tetrahydrochloride (0.05% vol/vol) and counterstained with hematoxylin. Negative controls were obtained in the absence of primary antibody or by preabsorbing the antibodies with blocking peptides (when commercially available). The images were digitized using a camera (Nikon) mounted on a conventional light microscope (Nikon), with magnifications of 1003 and 4003 used. Finally, the images were converted to TIFF format (bilevel scale) for analysis.
RNA Isolation and Quality Control
Total RNA was extracted from a pool of CL from each rat using TRIzol (Invitrogen Corp.) according to the manufacturer's instructions. The integrity of RNA samples was determined using an Agilent 2100 Bioanalyzer (Agilent Technologies), and all samples were estimated to be of high quality.
Complementary DNA Synthesis and TaqMan Quantitative Real-Time PCR
Reverse transcription was carried out on 1 lg of DNase-treated RNA in a 20-ll reaction volume using Moloney murine leukemia virus reverse transcriptase (Invitrogen) for 50 min at 378C. Real-time PCR was performed using the TaqMan PCR Reagent Kit with the 7500 Fast Real Time PCR System (Applied Biosystems). Primers and TaqMan MGB Probe for DLL4 ligand and NOTCH1 and NOTCH4 receptors were predeveloped and purchased from Applied Biosystems (catalog no. Mm00444619_m1, Rn 01758633_m1, and Rn 01525743_g1, respectively). The Rn18s mRNA was used as an active endogenous control in each well. Forward and reverse primers, as well as MGB Probe sequences for Rn18s, were as follows: 5 0 -CGGCTACCACATC CAAGGAA-3 0 , 5 0 -GGGCCTCGAAAGAGTCCTGT-3 0 , and 5 0 -CAG CAGGCGCGCAAATTACCCA-3 0 , respectively. Amplifications were conducted in a 10-ll final volume containing the NOTCH1, NOTCH4, or DLL4 probe (labeled with the reporter dye carboxyfluorescein), the RN18S probe (labeled with the 50 reporter dye VIC), forward and reverse primers, and TaqMan Universal PCR master mix. The number of amplification cycles required for the fluorescence to reach a predetermined threshold level (CT) was recorded for each unknown sample and for an internal standard curve. The internal standard curve, used for relative mRNA quantification, was generated from five 10-fold dilutions of pooled samples. CT values for unknown samples were used to extrapolate the amount of RNA equivalents from the internal standard curve. Relative expression of the target genes was normalized to RN18s rRNA levels, and the ratios were log-transformed before statistical analysis.
Western Blot Analysis
Five or six CL per rat were resuspended in lysis buffer (20 mM Tris-HCl [pH 8], 137 mM NaCl, 1% NP-40, and 10% glycerol) supplemented with protease inhibitors (Sigma) and homogenized with an Ultra-Turrax homogenizer (IKA Werk). Samples were centrifuged at 48C for 10 min at 10 000 3 g, and the resulting pellets were discarded. Protein concentration in the supernatant was measured by the Bradford assay. After boiling, samples were loaded onto the polyacrylamide gel, separated by 10-15% SDS-PAGE, and subsequently transferred to nitrocellulose membranes. Nonspecific binding sites were blocked overnight in TBS (4 mM Tris-HCl [pH 7.5] and 100 mM NaCl) containing low-fat powdered milk (5%) and Tween-20 (0.05%) at 48C. The membranes were then incubated overnight with the appropriate anti-rabbit or -mouse primary antibodies: anti-DLL4 (1:500; Abcam), anti-NOTCH1 (1:200; Cell Signaling Technology), anti-BCL2 (1:400; DAKO), anti-NOTCH4 (1:500; Santa Cruz Biotechnology), anti-BAX (1:200; Santa Cruz Biotechnology), and anti-CASP3 (1:200; Santa Cruz Biotechnology). Protein bands were visualized by incubating the blots for 1 h with peroxidase-conjugated secondary anti-rabbit IgG (1:1000; Sigma Chemical Co.). Finally, the membranes were incubated with Amersham ECL plus and exposed to radiographic film. Protein expression was quantified by densitometric analysis using Scion Image Software for Windows (Scion Corporation). The density in each specific band was normalized to the density of an internal control, glyceraldehyde phosphate dehydrogenase (1:10 000; Cell Signaling Technology).
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Serum P 4 Levels
Following ether extraction, P 4 levels were measured by radioimmunoassay in serum from the control and DAPT groups, as described previously [33] , using a specific antibody supplied by Dr. G.D. Niswender (Animal Reproduction and Biotechnology Laboratory, Colorado State University, Fort Collins, CO). Under these conditions, the intra-and interassay variations were 8.0% and 14.2%, respectively.
Statistical Analysis
Data are expressed as the mean 6 SEM. Experiments were repeated at least three times (n ¼ 5-6 animals/group). Data were analyzed using unpaired Student t-test. Differences were considered to be significant at P , 0.05. All data were assessed for heterogeneity of variance and found to be nonsignificant.
RESULTS
IHC of NOTCH1, NOTCH4, and DLL4 in CL from Pregnant Rats Figure 1 illustrates the presence and cell distribution of NOTCH1, NOTCH4, and DLL4 investigated in sections of rat ovaries obtained on Day 19 of pregnancy. Panels on the right in Fig. 1 illustrate higher magnification for each protein.
Specific staining for NOTCH1 and NOTCH4 receptors was detected predominantly in large and small luteal cells as well as in endothelial cells in the CL. In addition, positive staining was detected in ovarian blood vessels. No immunoreactivity was observed in the surrounding stroma (Fig. 1, A and B) . Furthermore, we detected positive staining for both receptors in the nuclei of luteal cells, in line with the fact that the NICD is translocated to the nucleus, where it regulates gene expression [34] .
Specific staining for the DLL4 ligand was also detected in large and small luteal cells as well as in endothelial cells. The ovarian blood vessels were also immunoreactive (Fig. 1C) . Notably, DLL4 staining was associated mainly with the cellular membrane defining the shape of the luteal cell. In addition, we detected a diffuse cytoplasmic immunostaining for DLL4 in luteal cells, in accordance with the fact that DLL4 undergoes proteolytic degradation after receptor binding [35] .
Messenger RNA Levels of Notch1, Notch4, and Dll4
During Luteolysis Induced by PGF2a
To determine whether expression of members of the notch pathway changes during luteolysis, we studied the mRNA expression of Notch1, Notch4, and Dll4 by real-time PCR in CL isolated on Day 19 of pregnancy, both 4 and 24 h after the administration of a luteolytic dose of PGF2a (Fig. 2) . The mRNA levels of both Notch1 and Notch4 receptors decreased 4 h after PGF2a administration compared with the control group   FIG. 1 . Localization of NOTCH1 and NOTCH4 receptors and DLL4 ligand in pregnant rat CL. A and B) Immunostaining for NOTCH1 and NOTCH4 was detected in large luteal cells (LL), small luteal cells (SL), endothelial cells (E), and blood vessels (V). Arrows indicate luteal nuclear staining for these receptors. C) DLL4 specific immunoreactivity was also found in E, LL, and SL (arrows), and V. No immunoreactivity was detected in the stroma (S) for NOTCH1, NOTCH4, or DLL4. Insets show negative controls. Bar ¼ 50 lm (left) or 20 lm (right).
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(4.30-fold and 1.38-fold, respectively; P , 0.05, n ¼ 6) (Fig. 2,  A and B) . Similarly, the levels of Dll4 mRNA were significantly lower in the PGF2a group than in the control group (3.6-fold; P , 0.001, n ¼ 6) (Fig. 2C) . However, 24 h after the PGF2a administration, no differences were found in the mRNA levels of Notch1, Notch4, and Dll4 between control and PGF2a groups (data not shown).
Protein Levels of NOTCH1, NOTCH4, and DLL4 During Luteolysis Induced by PGF2a
Based on the results obtained for mRNA, the protein levels of the notch members were determined by Western blot analysis in CL obtained 4 h after PGF2a administration (Fig.  3) . Analogous to the results obtained by quantitative PCR, administration of PGF2a to pregnant rats on Day 19 of pregnancy decreased the fragment corresponding to the cleaved forms of NOTCH1 and NOTCH4 receptors compared to the control group (2.4-fold and 1.5-fold, respectively; P , 0.05, n ¼ 6) (Fig. 3, A and B) . In contrast, no significant changes were detected in protein levels for the ligand DLL4 between groups (Fig. 3C) .
Involvement of Notch Signaling in CL Function and Apoptosis During Rat Pregnancy
To examine whether notch signaling influences the function and survival of luteal cells during pregnancy, we administered DAPT intrabursally to the ovary of rats on Day 19 of pregnancy. We first studied the cleavage of NOTCH1 in CL of pregnant rats 24 h after DAPT administration to verify if DAPT treatment was able to inhibit the notch signaling. By Western blot analyses of CL proteins, we detected a significant decrease of NICD in the DAPT group when compared to the control group (control, 1.00 6 0.10; DAPT, 0.75 6 0.04; P , 0.05, n ¼ 5-6). The local injection of DAPT produced a 1.9-fold decreased in serum P 4 levels 24 h after the treatment (control, 78.99 6 13.33 ng/ml; DAPT, 42.40 6 8.34 ng/ml; P , 0.05, n ¼ 5-6).
Western blot analysis of CL proteins using an anti-CASP3-specific antibody detected a significant increase, approximately 1.6-fold higher (P , 0.05, n ¼ 5), in the level of the active p17 form of CASP3 in the DAPT group when compared to the control group (Fig. 4A) . Nevertheless, no significant differences were found in the relative pro-CASP3 levels after the treatment (data not shown).
We next analyzed CASP3 protein expression by IHC studies in ovarian sections from DAPT-treated and control rats. Luteal cells in the DAPT group exhibited a high signal for CASP3 (Fig. 4C) . In contrast, luteal cells from the control group (Fig. 4B) showed low immunoreactivity for this protein.
Interestingly, CASP3 staining was more evident in the nuclei of the CL of the sections obtained from DAPT-treated ovaries than in those of the control group, in line with the fact that once activated, CASP3 translocates to the nucleus [36, 37] .
In light of these results, we examined the luteal content of the proapoptotic protein BAX and the antiapoptotic protein BCL2, two known regulators of ovarian apoptosis [38, 39] . Intrabursal injection of DAPT to pregnant rats significantly increased BAX protein expression (1.5-fold; P , 0.05, n ¼ 5-6) (Fig. 5A) and considerably decreased the levels of BCL2 protein (1.6-fold; P , 0.05, n ¼ 5-6) (Fig. 5B) relative to control levels. Consequently, the BAX:BCL2 ratio was significantly increased in CL obtained from ovaries treated with DAPT (P , 0.05) (Fig. 5C ).
DISCUSSION
The present study was designed to determine whether the notch pathway has a critical role in the luteolytic progression of CL from pregnant rats. We report here, to our knowledge for the first time, that 1) NOTCH1, NOTCH4, and the ligand DLL4 are expressed and localized in small and large luteal cells of CL from pregnant rats; 2) administration of the luteolytic hormone PGF2a decreased CL mRNA and protein expression of these notch family members; and 3) blocking the notch cleavage at the level of the gamma-secretase induced a decrease in circulating P 4 levels and an increase in the   FIG. 2. Notch1, Notch4 , and Dll4 mRNA levels in CL at 4 h after PGF2a administration on Day 19 of pregnancy. CL were obtained from animals of the control and PGF2a groups (n ¼ 6 per group). Notch1 (A), Notch4 (B), and Dll4 (C) mRNA levels were determined by quantitative PCR and normalized to Rn18s rRNA. Bars represent the mean 6 SEM. *P , 0.05.
FIG. 3. NOTCH1, NOTCH4
, and DLL4 proteins levels in rat CL at 4 h after PGF2a administration on Day 19 of pregnancy. CL were obtained from animals of the control and PGF2a groups (n ¼ 6 per group). NOTCH1 (A), NOTCH4 (B), and DLL4 (C) protein levels were determined by Western blot analysis and normalized to glyceraldehyde phosphate dehydrogenase (GAPDH). Bars represent the mean 6 SEM. *P , 0.05.
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activation of CASP3 and in the proapoptotic ratio of BAX to BCL2 proteins in CL. These results suggest that notch signaling plays a role in regulating the fate of luteal cells.
Previously, NOTCH2, NOTCH3, and JAG2 were localized by IHC to granulosa cells in developing follicles of mammalian ovaries, thus suggesting that the notch signaling pathway is involved in the regulation of folliculogenesis [29] . In addition, the suppression of notch signaling by gamma-secretase inhibitors in the neonatal mouse ovary decreases primordial follicle formation [40] . The expression patterns of NOTCH1, NOTCH4, and JAG1 proteins were also characterized during the process of folliculogenesis and CL formation in rodent ovaries, and it was shown that they are expressed in a subset of ovarian vessels, including mature ovarian vasculature and angiogenic neovessels, in both endothelial and vascularassociated cells [41] . Given the implications for cell growth, differentiation, and death in the CL life span, we investigated the role of the notch pathway in regression of CL during pregnancy in rats. It is known that CL development and luteolysis require dynamic changes in the ovarian vascular network; thus, treatments that disrupt the vasculature can affect luteal function in rodents [42] . In addition, among the notch family members, DLL4 and its receptors NOTCH1 and NOTCH4 have been recently identified as novel factors involved in the regulation of angiogenesis [26, 27, 43] . These observations have been the rationale for the present study about the notch system in CL function by analyzing DLL4 and NOTCH1 and NOTCH4 receptors.
Our data demonstrate both that notch pathway components are present in CL from pregnant rats and that the expression of the notch genes analyzed is dynamically regulated during the PGF2a-induced luteolysis. The diffuse staining of DLL4 and the localized immunoreactivity for NOTCH1 and NOTCH4 in the nuclei of luteal cells may be a result of the activation of the notch system in situ. Diffuse DLL4 staining appears to be common in the developing vascular system and in cancerous lesions when the cell contains both the ligand and notch receptors [44] [45] [46] . PGF2a treatment decreased mRNA and protein levels of NOTCH1, NOTCH4, and DLL4 at 4 h after administration. However, the decrease in mRNA levels was reversed at 24 h. This time difference could be explained by the classic signaling pathway of PGF2a, because this hormone interacts with its receptor and activates the Ca 2þ -dependent protein kinase C pathway, which is a rapid signal transduction mechanism [6] . Thus, the transient change in DLL4/NOTCH expression may be related to acute PGF receptor signaling at the onset of luteolytic events. Furthermore, we have examined DLL4 ligand as well as NOTCH1 and NOTCH4 receptor expression in other key stages of the CL life span (Days 12 and 21 of pregnancy and Day 4 postpartum). In our preliminary results, no significant differences were observed among groups (data not shown), suggesting that in the CL, these notch members are modulated by acute stimulation of luteolysis (e.g., PGF2a administration). We further investigated whether notch signaling has a direct effect on luteal cell survival. To this purpose, a gammasecretase inhibitor, DAPT, was intrabursally injected into 
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pregnant rats. A number of reports have indicated that notch can suppress apoptotic cell death [24, 47, 48] . In addition, it has been demonstrated that notch activation prevents apoptosis in breast cancer cell lines through activation of the PIK3/AKT pathway [49] . Another study reported that DAPT led to an increase in active CASP3 in both mouse insulinoma MIN6 cells and human pancreatic islets and, conversely, that gammasecretase overactivity resulted in protection from apoptosis [50] . However, most of these studies have been performed using freshly isolated cells and/or cell lines. One novel aspect of our present work is the attempt to study the role of the notch pathway in the regulation of luteal apoptosis in vivo. The fact that circulating P 4 levels decreased after local DAPT treatment confirms that NOTCH has a direct action on luteal function. We also found that the active CASP3 and the BAX:BCL2 ratio were significantly higher after DAPT treatment, suggesting that notch signaling is involved in the apoptosis of luteal cells associated with CL regression. Taking into account that the endothelial cells compromise approximately 50% of the CL cell population, we are performing studies to determine whether DAPT is able to affect CL vasculature. In previous studies, we demonstrated the association between an increase of CASP2, CASP8, CASP9, and CASP3 activity and a decrease of luteal P 4 content in pregnant rats treated with PGF2a [51] . We also observed that intrabursal administration of the antiapoptotic agent S1P to PGF2a-treated pregnant rats prevents caspase activation associated with luteolysis and causes an increase in the vascular area density of CL [22] . In addition, we demonstrated that follicular atresia is associated with an imbalance among the BCL2 family members [52] . These data, together with those from other studies [38, 53] , demonstrate that the intrinsic pathway of apoptosis is involved in follicular atresia. A similar mechanism could take part in the effect of notch on CL survival. However, a role of the apoptotic extrinsic pathway in this process cannot be discarded, because data also support the involvement of this pathway in luteal cell death [16, [54] [55] [56] .
Our results suggest that notch signaling has an important role in the survival of luteal cells. It is worth pointing out that alterations of NOTCH have been associated with different human cancers, including ovarian cancer [57] [58] [59] , implying that malfunction of this pathway can have significant consequences in the ovary.
In summary, we demonstrated that NOTCH1, NOTCH4, and the ligand DLL4 are expressed in small and large luteal cells of CL from pregnant rats and that the luteolytic hormone PGF2a decreases the CL mRNA and protein expression of these notch family members. In addition, NOTCH inhibition decreases circulating P 4 levels and increases proapoptotic markers, such as active CASP3 expression and the BAX:BCL2 ratio in CL from pregnant rats. These results support a luteotropic role for notch signaling to promote both luteal cell viability and steroidogenesis, and they suggest that the luteolytic hormone PGF2a might act in part by reducing the expression of some notch system components.
